Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH is a protected tetrapeptide fragment used in peptide synthesis and drug development. It contains strategically protected functional groups for stepwise coupling and features Aib (α-aminoisobutyric acid) to enhance helix stability and conformational rigidity.
Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH is a protected tetrapeptide fragment used in peptide synthesis and drug development. It contains strategically protected functional groups for stepwise coupling and features Aib (α-aminoisobutyric acid) to enhance helix stability and conformational rigidity.
Research & Applications
Useful in solid-phase peptide synthesis (SPPS)
Supports development of bioactive peptides and peptidomimetics
Aib residue improves peptide folding and enzymatic resistance
Product Features
High purity ≥99%
Boc, Trt, and OtBu protecting groups for selective deprotection
Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH is ideal for researchers working on stable and functional peptide therapeutics.
Frequently Asked Questions
What is Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH used for?
It is a protected tetrapeptide fragment primarily used in solid-phase peptide synthesis (SPPS) and the development of bioactive peptides, peptidomimetics, and peptide therapeutics.
What role does the Aib residue play in this compound?
The Aib (α-aminoisobutyric acid) residue enhances helix stability, increases conformational rigidity, improves peptide folding, and boosts enzymatic resistance.
What is the purity level of Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH?
The compound features a high purity level of ≥99%.
Which protecting groups are featured in this peptide fragment?
It incorporates Boc, Trt, and OtBu protecting groups designed for selective deprotection during stepwise coupling processes.
Why are strategically protected functional groups important?
Strategically protected functional groups allow for precise and selective deprotection, enabling efficient stepwise coupling in complex peptide synthesis.
Who can benefit from utilizing this product?
It is ideal for chemical and pharmaceutical researchers working on designing stable, functional, and bioresistant peptide therapeutics.
